Skip to main content
. 2021 Mar 16:myab009. doi: 10.1093/mmy/myab009

Table 2.

COVID-19 treatment received.

COVID-19 treatment CAPA (n = 16) Controls (n = 67) P-value
Hydroxychloroquine 14 (88) 56 (84) 0.71
Lopinavir/ritonavir 11 (69) 45 (67) 0.91
Azithromycin 12 (75) 56 (84) 0.43
Steroids 2 (13) 22 (33) 0.34
Tocilizumab 12 (75) 43 (64) 0.52

Here we show the COVID-19 treatment received by each group. There were no significant differences in the frequencies in which COVID-19 treatment was administered among both groups. All values are N (%).